Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 2
Submit an article Journal homepage
6
Views
2
CrossRef citations to date
0
Altmetric
Articles

Anti-vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies inhibit neointimal hyperplasia in the murine model of arterial injury

Jun-Ichi SuzukiThe Department of Cardiovascular Medicine, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.Correspondence[email protected]
,
Atsushi IzawaThe First Department of Internal Medicine, School of Medicine, Shinshu University, Tokyo, Japan.
&
Mitsuaki IsobeThe Department of Cardiovascular Medicine, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Pages 147-152 | Received 15 Dec 2003, Accepted 01 Aug 2003, Published online: 23 May 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Masahito Ogawa, Jun-ichi Suzuki, Yasunobu Hirata, Ryozo Nagai & Mitsuaki Isobe. (2009) A critical role of COX-2 in the progression of neointimal formation after wire injury in mice. Expert Opinion on Therapeutic Targets 13:5, pages 505-511.
Read now
Jun-ichi Suzuki, Masahito Ogawa, Susumu Muto, Yoichi Yamaguchi, Akiko Itai & Mitsuaki Isobe. (2008) The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury. Expert Opinion on Therapeutic Targets 12:7, pages 783-794.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.